Antibody-Drug Conjugates, T-Cell Engager Bispecific Antibodies and Chimeric Antigen Receptor T Cells for Multiple Myeloma: What's the Current Status?
Saved in:
| Title: | Antibody-Drug Conjugates, T-Cell Engager Bispecific Antibodies and Chimeric Antigen Receptor T Cells for Multiple Myeloma: What's the Current Status? |
|---|---|
| Authors: | Segers F; Laboratory of Experimental Hematology, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Hematology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium., Delforge M; Laboratory of Experimental Hematology, Department of Oncology, KU Leuven, Leuven, Belgium. Michel.delforge@uzleuven.be.; Department of Hematology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. Michel.delforge@uzleuven.be. |
| Source: | Targeted oncology [Target Oncol] 2026 Jan; Vol. 21 (1), pp. 63-86. Date of Electronic Publication: 2026 Jan 21. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41563628 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Antibody-Drug Conjugates, T-Cell Engager Bispecific Antibodies and Chimeric Antigen Receptor T Cells for Multiple Myeloma: What's the Current Status? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Segers+F%22">Segers F</searchLink>; Laboratory of Experimental Hematology, Department of Oncology, KU Leuven, Leuven, Belgium.; Department of Hematology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Delforge+M%22">Delforge M</searchLink>; Laboratory of Experimental Hematology, Department of Oncology, KU Leuven, Leuven, Belgium. Michel.delforge@uzleuven.be.; Department of Hematology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. Michel.delforge@uzleuven.be. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101270595%22">Targeted oncology</searchLink> [Target Oncol] 2026 Jan; Vol. 21 (1), pp. 63-86. <i>Date of Electronic Publication: </i>2026 Jan 21. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+France%22">Springer-Verlag France </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>101270595 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1776-260X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217762596%22">17762596 </searchLink><i>NLM ISO Abbreviation: </i>Target Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41563628 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s11523-025-01189-7 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 63 Titles: – TitleFull: Antibody-Drug Conjugates, T-Cell Engager Bispecific Antibodies and Chimeric Antigen Receptor T Cells for Multiple Myeloma: What's the Current Status? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Segers F – PersonEntity: Name: NameFull: Delforge M IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2026 Jan Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1776-260X Numbering: – Type: volume Value: 21 – Type: issue Value: 1 Titles: – TitleFull: Targeted oncology Type: main |
| ResultId | 1 |